Xiaowen Ge
发表
Nan Wang,
F. Zhong,
T. Zhu,
2018,
The Journal of Immunology.
T. You,
X. Qin,
Xiaowen Ge,
2011,
Cellular and Molecular Immunology.
J. Wong,
Q. Lei,
Pingzhao Zhang,
2020,
Theranostics.
Rupam Sahoo,
J. Halperin,
Pamela Ghosh,
2017,
Journal of diabetes and its complications.
Peng Liu,
Lijuan Yuan,
Zheng Wei,
2021
.
Yingyong Hou,
Yuan Ji,
J. Hou,
2017,
Diagnostic Pathology.
Yingyong Hou,
Shaohua Lu,
Yuan Ji,
2017,
Oncotarget.
J. Loscalzo,
R. Bronson,
Zhihai Peng,
2010,
Blood.
Yingyong Hou,
Shaohua Lu,
Yuan Ji,
2019,
Aging.
Yingyong Hou,
Qi Wang,
Wei Zhang,
2018,
Cell Death & Disease.
Xing-shun Li,
Xin Gao,
Mengyuan Liu,
2022,
SSRN Electronic Journal.
Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis.
Gongxiong Wu,
Jennifer R. Brown,
Zhihai Peng,
2011,
Cancer research.
S. Fernandes,
Jennifer R. Brown,
X. Qin,
2011,
Clinical Cancer Research.
Yingyong Hou,
Yuan Ji,
Xiaowen Ge,
2018,
International journal of clinical and experimental pathology.
Yingyong Hou,
Nan Wang,
Xiaowen Ge,
2021,
Frontiers in Oncology.
M. Chorev,
Yan Huang,
F. Liu,
2012,
Current pharmaceutical design.
Yingyong Hou,
Yun-shan Tan,
Yuan Ji,
2015,
World journal of gastroenterology.
Yingyong Hou,
Yun-shan Tan,
Yuan Ji,
2018,
International journal of clinical and experimental pathology.
Yingyong Hou,
Yuan Ji,
J. Hou,
2017,
Histopathology.
Yingyong Hou,
Yuan Ji,
J. Hou,
2017
.
Yingyong Hou,
X. Qin,
Yun-shan Tan,
2015,
Human pathology.
L. Tan,
Jie Huang,
Xin Wang,
2021,
Annals of translational medicine.
J. Wong,
Q. Lei,
Pingzhao Zhang,
2019,
bioRxiv.
Zhui Yu,
Jingping Yuan,
M. Ye,
2023,
Pathology, research and practice.
Yingyong Hou,
Wei Zhang,
Peipei Ding,
2018,
Cell Death & Disease.